ARTICLE | Clinical News
Fesoterodine: Phase II data
August 30, 2004 7:00 AM UTC
In a double-blind international Phase II trial in 728 patients, fesoterodine reduced micturition frequency and number of urge incontinence episodes compared to placebo. The most frequently reported ad...